James M Frates is a director of Sage Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Amylyx Pharmaceuticals, Inc.
18 Apr 24
4
Amylyx Pharmaceuticals, Inc.
7 Mar 24
4
Amylyx Pharmaceuticals, Inc.
28 Feb 24
4
Amylyx Pharmaceuticals, Inc.
11 Jan 24
4
Sage Therapeutics, Inc.
4 Jan 24
4
Amylyx Pharmaceuticals, Inc.
2 Nov 23
4
Amylyx Pharmaceuticals, Inc.
24 Aug 23
4
Sage Therapeutics, Inc.
16 Jun 23
4
Amylyx Pharmaceuticals, Inc.
18 May 23
144
Amylyx Pharmaceuticals, Inc.
16 May 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Apr 24 | AMLX Amylyx Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 91,180 | 0.00 | 225,964 |
16 Apr 24 | AMLX Amylyx Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 2.01 | 120,000 | 241.20 k | 120,000 |
26 Feb 24 | AMLX Amylyx Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 152,035 |
26 Feb 24 | AMLX Amylyx Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 17.56 | 60,000 | 1.05 mm | 60,000 |
9 Jan 24 | AMLX Amylyx Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 16.3281 | 2,716 | 44.35 k | 112,035 |
3 Jan 24 | SAGE Sage Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 21.67 | 4,925 | 106.72 k | 4,925 |
31 Oct 23 | AMLX Amylyx Pharmaceuticals | Common Stock | Gift | Acquire G | Yes | No | 0 | 11,072 | 0.00 | 11,072 |